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ABSTRACT
The spiral Salmonella mutagenicity assay has been
employed to examine whether binary combinations of pure
chemicals and complex mixtures result in additive
mutagencity responses.  Single chemicals were selected that
were representative of the primary chemical class
responsible for much of the mutagenic activity of each
complex mixture.  The following agents were evaluated in the
absence of S9:  1-nitropyrene (INP), diesel exhaust extract
(DE), and 3-chloro-4-dichloromethyl-5-hydroxy-2-[5]-furanone
(MX).  In the presence of S9 the following agents were
evaluated:  4-aminobiphenyl (4AB), cigarette smoke
condensate (CSC), benzo(a)pyrene (BAP), polyethylene
incinerator effluent (PE), pentachlorophenol (PCP), and wood
preserving waste (WPW).  All possible binary combinations of
these agents were tested.
The results were analyzed for response additivity to
determine whether the difference between the expected
response of the binary mixture, and the observed response
was statistically significant.  The combinations of direct-
acting mutagens elicited an essentially additive response;
whereas, the combinations of indirect-acting mutagens
produced generally a subadditive response.  Exogenous
activation proved to be a confounding factor in this
interaction study.
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11.0 INTRODUCTION
Humans are exposed to man-made and naturally occurring
mutagens every day.  It is reasonable to assume that
exposure to more than one agent may occur simultaneously.
Therefore, the interactions between these chemicals or
complex mixtures should be studied to determine the effects
of combinations of mutagens.
A common assumption regarding chemical mutagens is that
the mutagenic potency of combinations of two or more
mutagens will be additive.  This assumption is based mostly
on limited toxicological data in which the toxicity from a
pair of compounds was usually the sum of the toxic response
to the single chemicals.  The assumption of additivity
greatly simplifies the risk assessment of more than one
chemical agent.  However, most of the studies that have
addressed the interaction of two mutagens have rarely
demonstrated additivity, especially when metabolic
activation is involved.
Most short-term interaction studies for mutagenicity
have used the Salmonella mutagenicity assay.  However,
relatively few of these investigations have explored the
effects of two mutagens together.  Most studies have
examined the effect of comutagens on other mutagens.  The
primary focus of such studies has been to determine the
ability of a nonmutagen to potentiate or inhibit the
activity of a mutagen.
2In order to extend these interaction studies, the
spiral Salmonella assay has been employed to explore more
efficiently and systematically the response of binary
combinations of pure chemical and complex mixtures.  The
spiral assay can be performed in less time and uses less
material than the plate-incorporation assay for equivalent
experimental schemes (Houk et al., 1989).  The spiral assay
has the added advantage of dispensing a gradient of S9
concentrations from a single S9 mix, permitting one to
determine the effect of S9 on the mutagenic response.
Some of the binary combinations investigated here were
also analyzed with the Salmonella plate-incorporation assay
to compare the results of the two assay systems.  Several
concentrations (9%, 18%, and 27%) of S9 mixes were used in
the plate-incorporation assay to determine the effect of
exogenous activation on interaction assays.  In order to
simplify the testing scheme, mutagenic compounds and complex
mixtures were selected that could be detected by the same
strain (TA98).
Several common environmental complex mixtures to which
humans have the potential to be exposed were chosen for this
study.  The mixtures were (1) an emission sample from the
incineration of polyethylene, (2) diesel engine exhaust, (3)
cigarette smoke condensate, and (4) wood-preserving waste.
Pure chemicals were chosen that are found commonly in each
complex mixture and that represent the chemical class
3responsible for much of the mutagenic activity of each
mixture.  Relative to the complex mixtures described above,
these were BAP, INP, 4AB, and PCP, respectively.  MX was
also included in this study because it represents an
important exposure through chlorinated drinking water.  PCP
is not mutagenic in Salmonella, but it was included because
it is genotoxic at other endpoints and in other systems and
because it is a major component of wood-preserving waste.
42.0 LITERATURE REVIEW
2.1 Premise for the Additivity Assiimption
A common assumption regarding chemical mutagens is that
mutagenic potency or activity of combinations of two or more
mutagens will be additive.  This assumption greatly
simplifies estimating the potency of complex mixtures based
on chemical analysis.  For example, the mass of mutagens in
an uncharacterized complex mixture has been estimated by
Schaeffer and Kerster (1985) by assuming response additivity
of extracted fractions.  Pairs of twenty-seven industrial
chemicals were assayed for joint toxic action in rats by
Smyth et al. (1968) who found that the LDsQOf binary
mixtures could be predicted satisfatorily by the additivity
assumption.
2.2 Combinations of Two Mutagens in Salmonella
Most studies of the effects of binary combinations of
organic mutagens have been performed in the Salmonella
plate-incorporation assay.  Most of this literature involves
the interaction of a mutagen with a comutagen, a nonmutagen
that enhances the activity of a mutagen, or an inhibitor, an
agent that inhibits the effect of a mutagen, to determine
whether a nonmutagenic chemical will affect the activity of
a mutagen.  Although the focus of the present study is the
interaction of two mutagens, I will discuss some of the
literature on the interaction of an organic mutagen with a
comutagen in order to provide an overview of interaction
5studies in general.  Many studies of the comutagenicity of
metals have been performed; however, they will not be
discussed here.
Many different terms have been used to express the
response of binary combinations of compounds, frequently
with the same expression having dissimilar meanings,
depending on the author.  In this report, especially in the
Results and Discussion section, the terms superadditive,
additive, and subadditive will be used to represent an
observed response that is more than, equal to, and less
than, respectively, the expected of the sum of the two
compounds alone.  These terms provide a simple way to
characterize the results and are more amenable to a
statistical definition than are terms such as synergism or
antagonism.
Interactions involving some of the compounds and
complex mixtures listed above have been performed previously
using a variety of methods.  Also, different types of
evaluations, from visual examination of the dose-response
curves to statistical analyses, have been applied to the
data.  The use of ratios to demonstrate the contribution of
one compound to the response of the pair has been used
frequently by investigators.  These types of calculations
address only indirectly the additivity assumption and may
magnify the degree of deviation from additivity.  The ratio
that directly addresses the question of additivity is the
6mutagen interaction ratio (MIR) (Hass et al., 1981).  The
MIR is simply the calculation of the observed response of
the pair divided by the expected response of the pair (the
sum of the responses of the individual components).  Care
has been taken in this review of the literature to present
the authors conclusions as well as an analysis appropriate
to the question of response additivity.
BAP and kerosene soot extract produced an additive
response in a forward-mutation assay in Salmonella strain
TM677 (Kaden et al., 1979).  A single concentration of soot
extract was tested with a range of doses of BAP.  The
response of the soot and BAP mixture was essentially equal
to the sum of the response of the soot and BAP assayed
separately, suggesting additivity.  Kaden et al. also found
that the mutagenic potency of the polycyclic aromatic
hydrocarbon- (PAH) containing fraction of soot could be
accounted for by summing the individual potencies of the
major component PAHs characterized by chemical analysis.
BAP and benzo(rst)pentaphene were assayed singly in
strain TA98 with their optimal S9 concentration and then
paired with the sum of the S9 concentrations in TA98
(Salamone et al., 1979).  The investigators found that this
resulted in a subadditive response.  Salamone et al. also
assayed the direct-acting mutagens ethyl methane sulfonate
and methyl-nitro-nitrosoguanidine (MNNG) together and found
an additive effect.  The dose-response curves for the
7individual chemicals, the combination, and the theoretical
sum were plotted and examined visually to evaluate the
responses.  The authors concluded that binary combinations
of direct-acting mutagens are additive but that additivity
might not be observed with binary combinations of
promutagens due to the interference by the S9 mix.
Binary combinations of various aminocarbolines were
assayed in TA98 (Yoshida et al., 1979).  It was determined
that 3-amino-l-methyl-5H-pyrido[4,3-b]indole (II) and 2-
amino-9H-pyrido[2,3-b]indole (III) produce a superadditive
response together.  Other binary combinations of II, III, 3-
amino-1,4-dimethyl-5H-pyrido[4,3-b]indole, 2-amino-3-methyl-
9H-pyrido[2,3-b]indole, BAP, and 2-acetylaminofluorene
(2AAF) were assayed in binary combination.  Only
combinations of BAP or 2-AAF with II or III resulted in a
superadditive response.  The authors also observed a
decrease in the response of TA98 to single applications of
II and III as the concentration of S9 was increased.  The
response of the binary combination went from subadditive to
superadditive as the S9 concentration increased, suggesting
that exogenous activation exerts a complex influence in
interaction studies.
Somani et al. (1981) reported that the effects of
mixtures containing up to 11 compounds were generally
additive in spot tests with regards to toxicity and
mutagenicity.  Eleven direct-acting compounds were assayed
8in three Salmonella strains, both singly and in mixtures,
and the zones of toxicity and mutagenicity were measured in
an attempt to quantify the results.  Most of the compounds
were negative in the three strains, so it is not surprising
that additive effects were observed when the nonmutagens
were assayed with mutagens.  In TA98, 2-nitrofluorene was
mutagenic and nontoxic, and azaserine was weakly mutagenic
and toxic.  The result of the two together was a toxic,
nonmutagenic response.  Azaserine and nitrofurantoin were
mutagenic in TAIOO, but exhibited toxic responses.  The pair
together exhibited a subadditive response.  9-Aminoacridine
was the only mutagen evaluated in TA1537 and was assayed
with nonmutagens.  There was a general trend toward
increasing toxicity as more compounds were applied to the
well, not neccessarily an increase in mutagenicity.  These
results suggest that the toxicity of a compound may play a
role in the response of a pair of compounds and that results
of mixtures of nonmutagens may be difficult to interpret.
Binary mixtures of 2-aminoanthracene (2AA) and benzene
produced a strictly additive response in TA1538 with
Arochlor-induced rat liver S9 (Kawalek and Andrews, 1981).
Naphthalene, anthracene, or phenanthrene produced
superadditive results with 2AA under the same conditions.
In this study the results were graphically expressed as the
percentage of 2AA activity versus the concentration of
aromatic hydrocarbon.
9Mutagenic PAHs when combined with a mutagenic dose of 1
/ig/plate of BAP have produced a superadditive response at
low doses followed by an subadditive effect at high doses
(Hermann, 1981).  The effects were evaluated by plotting the
response of the PAHs to a single dose of BAP and observing
an increase or decrease in the dose response curve.  PAHs
with five or more rings greatly decreased the activity of
BAP compared with those PAHs with less than five rings.
Quercetin, a mutagenic flavenoid (Sugimura et al.,
1977), increased the mutagencity of 2AAF by 2.2 to 5.0 fold,
but did not affect the response of 4-nitroguinoline-l-oxide
(4NQ0) (Ogawa et al., 1985) when two doses of quercetin were
assayed with two doses of the mutagens in TA98.  BAP in the
presence of quercetin showed a subadditive response at the
low dose and a barely superadditive response at the high
dose.  The difference in the observed and expected responses
was expressed as a fold increase or decrease, but this paper
is unclear as to the formula used to arrive at this ratio or
the criteria for declaring enhancement or depression.
Ogawa et al. (1987) further explored the effect of
quercetin on 2AAF and its metabolites.  The effect of
quercetin on 2AAF, N-hydroxy-acetylaminofluorene, 2-
aminofluorene (2AF), or N-acetoxy-acetylaminofluroene was
superadditivity.  A ratio of the response of the binary
mixture minus the response of quercetin alone divided by the
response of the other chemical was used to evaluate the
10
results.  This approach tended to maximize the difference
from strict additivity more than the MIR.
Hass et al., (1987) tried a different approach to the
analysis of binary mixtures.  The authors assayed binary
combinations of isomers of nitrobenzo(a)pyrene (NBP) in the
plate-incorporation assay where the total mass of NBP on all
the plates was 0.4 mg.  The dose schemes of the two
compounds were the inverse of each other.  The dose response
was plotted with the percent mass of one of the compounds on
the X axis and a line connecting the revertant values of the
single solutions was drawn.  Presumably, if the various
ratios of the two NBPs were additive, their dose response
would be similar to or near this line.  If the response was
superadditive or subadditive, then their dose response would
be above or below the line, respectively.  Hass et al.
determined that all three binary combinations of the three
NBP isomers exhibited a statistically superadditive response
in TA98 without S9.  BAP and 1-NBP or 3-NBP also produced a
superadditive response under the same conditions.
Binary combinations of 1-NBP and 3-NBP were
demonstrated to induce a superadditive response in TA98NR
without S9 (Thornton-Manning et al., 1989) by the same
experimental and analysis method of Hass et al. (1987).  The
combination of 1- and 3-nitrosobenzo(a)pyrene, reduction
products of 1- and 3-NBP, produced a subadditive effect in
TA98.
11
CSC at a mutagenic dose of 0.2 mg/plate resulted in a
superadditive response when combined with 2AF, 2AAF, 4-
acetylaminofluorene, and 2AA in TA98 (Crebelli et al.,
1991).  The same concentration of CSC when mixed with 2,4-
diaminotoluene, furazolidone, quercetin, and 2,4,7-trinitro-
9-fluoreneone produced clear subadditive responses.  These
investigators used 10% S9 for the single chemicals and the
combinations requiring metabolic activation.  Crebelli et
al. evaluated their data by dividing the revertants induced
in the presence of the CSC and the chemical by the
revertants induced by the single compound in the absence of
CSC.  This analysis magnifies the difference from additivity
more than the MIR.  The revertant counts of the CSC alone
were subtracted from of the revertant count of the binary
combination when S9 was not present.
Tetandrine, a weak promutagen in TA98, produced
superadditive responses when combined with BAP,
trinitrofluorenone, 2AA, diesel emission particles, CSC,
aflatoxin Bi, and fried beef extract (Whong et al., 1989).
The activity of diesel emission or fried beef with
tetandrine became more superadditive as both doses
increased.  The authors expressed the degree to which
tetandrine increased the expected response of the pure
compounds or complex mixtures alone by percent enhancement,
which they derived by subtracting the revertants induced by
the mutagen from the revertants induced by the binary
12
combination and dividing by the revertants induced by the
mutagen.  This approach does not directly address the
deviation from additivity.
Phenobarbital, a weak mutagen in strain TA1535, and
4NQ0 produced an additive response when assayed together
without S9 in this strain (Albertini and Gocke, 1992).
Phenobarbitol and sodium azide (NaN3) exhibited a
superadditive response in the presence and absence of S9.  A
superadditive response resulted from the combination of
phenobarbitol and 2AA in the following strains: TA1535,
TA1537, TA1538, TA97, TA98, TAIOO, and TA102.  These
conclusions were reached by visual examination of the dose-
response curves and professional judgement.
2.2.1 Summary
Additive, superadditive, and subadditive effects have
been observed for combinations of promutagens depending on
the agents involved.  Subadditive responses are the most
common, and some investigators have speculated that the
addition of S9 may have a confounding influence.  Additive,
subadditive, and superadditive effects are also seen in the
absence of S9, although there are far fewer studies
involving pairs of direct-acting mutagens than of indirect-
acting mutagens.
2.3 Combinations of a Mutagen and a Nonmutagen in
Salmonella
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Comutagens are agents that are nonmutagens that enhance
the activity of mutagens.  The following is a review of
studies of a comutagen or an inhibitor with another mutagen.
Silverman and Andrews (1977) tested 30 bile acids in
seven Salmonella tester strains and found that they were not
mutagenic. However, when binary combinations of a bile acid
and 2 ng  of 2-AA were assayed together with S9, a
superadditive response was observed for four of the bile
acids in strain TA1538.
Diethylstilbestrol, a nonmutagen in TA1538, induced a
clear superadditive response with 2AAF and a weak direct-
acting mutagen N-hydroxy-N-2-acetylaminofluorene with the
presence of 3-methylcholanthrene-induced rat liver S9
(Allaben et al., 1979).  The dose responses were examined
and the increase was expressed as the fold increase in the
number of revertant colonies above the response of the
aromatic amines alone.  The actual observed response was
less than stated because the background counts were not
subtracted, but superadditivity was apparent.
Studies have shown a superadditive response of TA98 to
BAP or 2AAF with the comutagen benzo(e)pyrene (BEP) (Rao et.
al., 1979).  A range of 2AAF and BAP concentrations were
assayed against a range of BEP in the presence of a single
concentration of S9.
Mixtures of BEP (0.6 - 2.5 ug/plate) and BAP (0.5 - 2.5
ug/plate) have also shown a superadditive response in TA98
14
(Hass et al., 1981).  In this study, Hass used a range of
doses for both chemicals and the same concentration of S9
for the single as well as the combination of compounds.
Hermann (1981) demonstrated an inhibition of activity
for BAP (1.5 - 5.0 ug/plate) when mixed with BEP (15-50
ug/plate), while confirming superadditivity at the lower
concentrations of the two chemicals.  A single concentration
of S9 was used in this study.
Catechol, a nonmutagen in TA98, was found to inhibit
the activity of BAP at low S9 concentrations and to enhance
activity at high S9 concentrations (Yoshida and Fukuhara,
1983).  The activity of the direct-acting mutagen 4NQ0 was
inhibited in the presence of catechol.  The doses of the
mutagens were held constant, while the dose of the comutagen
varied.
(+)-Catechin inhibited the indirect-acting aromatic
amines 2AF and 4AB, but it had no effect on the direct-
acting mutagens 9-aminoacridine or MNNG (Steele et al.,
1985).  This study used twice the standard concentration of
S9.
Tannic acid inhibited the response of TAIOO to BAP
(Vance and Teel, 1989).  The study explored a single dose of
BAP and a dose range of tannic acid.
Using TA98, the response of BAP was enhanced by 6-
nitro-4,2^,3^,4^,5^-pentachlorobiphenydnd 2-nitro-3,7,8-
trichloro-dibenzo-p-dioxin (NTCDD) (Donnelly et al., 1988).
15
S9 (30%) was used for the single chemicals and their
combinations.  Donnelly et al. tested a constant dose of one
chemical versus a range of the other.
Donnelly et al. (1990) reported that PCP or NTCDD,
which are nonmutagenic components of wood-preserving waste,
produced superadditve results when assayed with BAP.  Octa-
or hepta-chlorodibenzo-p-dioxin, nonmutagens, produced
additive effects with BAP.  However, the effects of these
four comutagens were determined from the nonlinear portion
of the dose-response curve of BAP at doses that elicit
toxicity.  In fact, the results from the linear portion of
the curve indicate strict additivity in all cases.
Erythrosine (FD and C Red 3) was reported to inhibit
the mutagenicity of BAP, NaN3, mitomycin C, and MMS
(Lakdawalla and Netrawali, 1988).  However, the validity of
this conclusion is questionable because erythrosine was
toxic at some of the doses at which it was tested with the
other chemicals.
Verampamil is a nonmutagenic calcium channel-blocking
agent that is used as a heart medication.  In combination
with some anilinoacridines, DNA-binding anticancer drugs,
acridine derivatives, antiparisitic drugs, and a biological
stain, varampimil produced superadditive or subadditive
effects (Ferguson and Baguley, 1988).  Ferguson et al.
(1990) also report that verampamil induced superadditive or
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subadditive results depending on the type of hair dyes with
which it was combined in Salmonella.
2.4 Interaction Studies in Other Test Systems
The response of Drosophila to a mixture of four
mutagens, diethyl nitrosamine, 2,3,5,6-tetra-ethyleneimino-
1,4-benzoquinone, methyl methanesulfonate, and l-(2,4,6-
trichlorophenyl)-3,3-dimethyltriazene, was additive (Vogel,
1979).  Superadditivity in Chinese hamster ovary cells was
observed when an extract of diesel-exhaust particles was
combined with BAP and MNNG (Li and Royer, 1982).  Sister
chromatid exchanges and chromosome aberrations were
superadditive in workers exposed to l-propoxy-2-acetamino-4-
nitrobenzol who smoked tobacco compared to those that did
not smoke (Tanner et al., 1990).
2.5 Chemicals and Complex Mixtures in the Environment
Complex mixtures of man-made pollutants occur in the
environment due to their formation by human activity.  They
are made up of pure chemicals that often belong to several
chemical classes.  For example, wood-preserving waste
contains pentachlorophenol, a chlorophenol, and creosote, a
mixture of PAHs.  CSC contains 4-aminobiphenyl, an aromatic
amine, and BAP, a PAH.  Usually, a single chemical class is
responsible for most of the mutagenicity of the mixture.  A
well-studied pure compound that is representative of that
chemical class was selected in the present study to be
paired with the complex mixture in which it is found.  Both
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direct- and indirect-acting chemicals and complex mixtures
were selected.  The following describes the mixtures, the
pure compounds, and their occurrence in the environment.
2.5.1 1-Nitropyrene and Diesel Exhaust
INP has been shown to be a potent direct-acting
frameshift mutagen in TA98 and other Salmonella strains
(Mermelstien et al., 1981).  Nitroarenes are probably formed
by nitration of PAHs during combustion of organic material.
This chemical has been identified in diesel exhaust
particulate (Pitts et al., 1982; Nakagawa et al., 1983) and
in used crankcase oil from a diesel engine (Manabe et al.,
1984).  1-NP has been shown to contribute from 12 to 24% of
the mutagenicity of diesel particulate extracts (Salmeen et
al., 1982).  Exhaust from diesel engines has been found to
be mutagenic in Salmonella (Ohnishi et al., 1980; Claxton,
1981; Dukovich et al., 1981).
2.5.2 MX
Chlorination of naturally occurring humic acids in
water to produce drinking water causes chlorinated organics
to be formed (Cheh et al., 1980).  MX was isolated from pulp
chlorination liquors and identified by Holmbom et al,
(1981). MX has been found to be mutagenic in strain TAIOO
(Holmbom et al., 1984; Hemming et al., 1986; Meier et al.,
1987a; Meier et al., 1987b; Tikkanen and Kronberg, 1990) and
TA98 (Hemming et al., 1986; Meier et al., 1987a; Tikkanen
and Kronberg, 1990).  Other mutagenic compounds were found
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in chlorinated drinking water, but those identified
accounted for only 2% of the mutagencity in TA98 (Meier et
al., 1985).  MX accounted for a significant portion (15 to
34%) of the mutagencity of drinking water samples taken at
plants in the U.S. that use chlorine disinfection in TAIOO
(Meier et al., 1987a). MX was responsible for 20 to 50%
(Kronberg et al., 1988) and 15 to 57% (Kronberg and
Vartiainen, 1988) of the mutagenicity in TAIOO of
chlorinated drinking water samples in Finland.
2.5.3 4-AminobiphenYl and Cigarette Smoke
4-Aminobiphenyl, an aromatic amine, is a known animal
carcinogen (Miller and Miller, 1967) and is positive in the
Salmonella assay with hepatic microsomes from several
species (Phillipson and loannides, 1983).  The genotoxicity
of cigarette smoke has been reviewed in detail (DeMarini,
1983).  The aromatic amines are found in the basic fraction
of CSC (Kier et al., 1974) where most of the mutagenicity is
found (Lofroth and Lazardis, 1986); whereas, PAHs are
located in the neutral fraction (Kier et al., 1974).
Mainstream cigarette smoke from American and Swedish brands
has been shown to be mutagenic in TA98 (Lofroth and
Lazaridis, 1986).
2.5.4 Benzo(a)pyrene and Incinerator Emsissions
Davies et al. (1976) established that PAHs were formed
by the incomplete combustion of municipal waste and that BAP
was present in the emissions.  There are a few examples of
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testing incinerator emissions for mutagenicity.  Municipal
incinerator gas was found to be mutagenic in TA98 and to
contain BAP (Kamiya and Ose, 1987).  A rotary kiln
incinerator equipped with an afterburner was used to combust
polyethylene under upset conditions, resulting in a potent
mutagenic effluent (DeMarini et al, 1992), as did the same
conditions but without an afterburner (DeMarini, unpublished
data).  The emissions from a municipal waste combustor and a
hospital waste combustor were shown to be mutagenic in TA98
with and without S9 (Watts et al., 1992).  A PAH analysis of
the rotary kiln, the municipal waste combustor, and the
hospital waste combustor showed that BAP was present in all
of the emissions (Williams et al., in press).  BAP is a
well-studied mutagenic PAH, which is also a known
carcinogen.
2.5.5 Pentachlorophenol and Wood-Preserving Waste
Wood-preserving waste extract from a plant using
creosote and PCP to preserve wood has been shown to be
mutagenic in the Salmonella and Aspergillus assays (Donnelly
et al., 1987a) and to cause DNA damage in repair-deficient
Bacillus subtilis (Donnelly et al., 1987b).  Not
unexpectedly, PCP was identified in the acid fraction of
this waste (Donnelly et al., 1987b).
PCP and other isomers of chlorophenol are used as a
wood preservative and a pesticide.  PCP is readily absorbed
by humans through all routes of occupational exposure
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(Williams, 1982).  Although PCP is not mutagenic in
Salmonella (Haworth et al., 1983), it elicits a strong
response from E. coli in the Microscreen prophage-induction
assay, which is more sensitive to chlorophenols than is the
Salmonella assay (DeMarini et al., 1990).  Thus, PCP was
used not to examine additivity but the possibility of
comutagenicity.
2.6 Salmonella Plate-Incorporation Assay
The Salmonella plate-incorporation assay, commonly
referred to as the Ames test, is used widely to test
compounds and complex mixtures for mutagenicity (Kier et
al., 1986).  The assay uses mutant histidine-requiring
strains of Salmonella typhimurium that can revert to
prototrophy if a mutagen induces an appropriate mutation.
Strain TA98, a derivative of LT2, has the hisD3052 mutation
in the hisD gene that codes for the enzyme histidinol
dehydrogenase, which is the last enzyme in the histidine
biosynthetic pathway.  The hisD3052 mutation is a -1
frameshift that causes a shift in the reading frame that
results in a stop codon, thus stopping histidine production.
A trace amount of histidine in the medium is provided to
permit the cells to undergo several cell divisions in the
presence of the mutagen, thereby providing the opportunity
for the cell to convert the mutagen-induced DNA lesion into
a mutation.
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Additional mutations that make the cells more
responsive to mutagens include the mutation in the uvrB
nucleotide excision-repair gene, which repairs certain types
of DNA damage; the mutation in the rfa (deep rough) gene,
which codes for a component of the cell wall, thus rendering
the cell more permeable to large molecules; and the addition
of the R-factor plasmid, pKMlOl, which contains the mucAB
genes that confer error-prone translesion synthesis, which
causes some types of DNA damage to be processed into
mutations.
The cells are exposed either in the presence or absence
of exogenous activation to the mutagen, which is usually
dissolved in a nontoxic solvent, by being mixed together in
molten top agar and poured onto minimal medium plates.  The
plates are incubated for several days to allow colony
formation.  If the mutagen causes DNA damage that is
processed in such a way that the resulting mutation restores
histidine production, revertant colonies grow on the minimal
medium.
The number of revertants are counted and recorded.  If
several doses have been tested, a dose-response curve may be
plotted.  Mutagenic potency, the number of revertants per
unit mass of mutagen, can be determined from the slope.
Generally, a response of two or more fold over the
background mutant yield is interpreted as a positive
response.
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2.7 Spiral Salmonella Assay
The spiral Salmonella assay is a semi-automated version
of the plate-incorporation assay.  The assay was developed
to automate bacterial mutagenicity testing in order to
conserve labor, time, and sample volume (Houk et al., 1989).
The spiral plater dispenses the bacterial culture, dissolved
sample, and S9 in a spiral pattern on an agar plate.  The
revertants are counted with a laser scanner, and the counts
on each spiral are corrected to typical plate counts.  This
system has also been shown to be useful for testing complex
mixtures (Houk et al., 1991).
The spiral assay has the added advantage of permitting
the delivery of the sample in dichloromethane (DCM), which
is used to extract complex mixtures.  However, DCM is highly
toxic to the Salmonella tester strains and cannot be used in
the plate-incorporation assay.  In the spiral assay, after
the complex mixture or chemical is delivered in DCM, the DCM
is allowed to evaporate and the other components are
applied.
2.8 Mutagenesis as a Step Towards Carcinogenesis
DNA damage that results in a mutation is believed to be
the first step in carcinogensis.  The development of cancer
is thought to be a multistep process involving initiation,
promotion, and progression—steps that may also involve
mutation.  The number of genetic alterations in colorectal
tumors has been found to increase in each successive stage
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of the adenoma (Fearon and Vogelstein, 1990).  Although
bacteria cannot assay the carcinogencity of a compound
directly, the majority of rodent and human organic chemical
carcinogens are mutagenic (Tennant et al., 1987; Shelby et
al., 1988).
2.9 Meunmalian Metaibolic Activation in Short-Term Assays
Chemical mutagens that are inactive unless they are
converted to reactive molecules are known as promutagens.
The conversion of a promutagen to a form that is able to
react with DNA and thus cause genetic damage is caused by
the cell's attempt to detoxify the xenobiotic compound and
eliminate it by making the molecule more water soluble.
Although bacteria have enzymes to metabolize foreign
molecules, a mammalian metabolic system is added to the
Salmonella assay to provide metabolic activation that is
related more closely to that of humans.
Promutagens can be activated to active species in the
Salmonella plate-incorporation assay by the addition of
mammalian activation enzymes (Mailing, 1971).  Standard
procedures for performing the Salmonella plate-incorporation
assay have been described (Ames et al., 1975; Maron and
Ames, 1983).  Exogenous activation in the plate-
incorporation assay has been to found contribute most of the
variability (Claxton et al., 1987).
To elicit the highest activity possible from a given
chemical, an optimum 89 concentration is required and this
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concentration varies among compounds.  Optimal S9
concentrations have been identified for organic extracts of
combustion emissions (Williams and Lewtas, 1985) and for
various pure compounds.
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3.0 MATERIALS AMD METHODS
3.1 Chemicals, solutions and Media
3.1.1 Chemicals
B&J Brand DMSO (081) and DCM (300) were obtained from
Baxter (McGaw Park, IL).  Ethyl alcohol was purchased from
Midwest Grain Products Co. (Weston, MO).  Difco Bacto-Agar
and dextrose were also furnished by Baxter.  Oxoid nutrient
broth No.2 (CM67) was supplied by Oxoid Ltd. (Basingstoke,
Hampshire, England).  Magnesium sulfate (6066), sodium
phosphate monobasic (7892) , sodium phosphate dibasic (7917),
magnesium chloride (5958), and potassium chloride (6858)
were purchased from Mallinckrodt (Paris, KY).  The following
chemicals were obtained from Fisher Scientific (Fairlawn,
NJ): citric acid monohydrate (A104), potassium phosphate
dibasic anhydrous (P288), sodium ammonium phosphate (S218),
and sodium chloride (S271).  Sigma Chemical Co. (St Louis,
MO) supplied 2-anthramine (A1381), 4-aminobiphenyl (A2898),
pentachlorophenol (P1045) , benzo(a)pyrene (B1760), )3-
nicotinamide adenine dinucleotide phosphate (N505), glucose-
6-phosphate (G7879), D-biotin (B4501), and L-histidine
(H8152).  2-Nitrofluorene (Nl,675-4) was obtained from
Aldrich Chemical Company (Milwaukee, WI).  Male Sprague-
Dawley Arochlor-induced rat liver S9 was purchased from
Organon Teknika (West Chester, PA).  3-chloro-4-
(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) was kindly
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provided by Dr. Paul Ringhand, U.S. Environmental Protection
Agency, Cincinati, OH.
3.1.2 Solutions
The solutions used in the media and S9 mix were
prepared as follows:
Vogel-Bonner Medium E (VBME) SOX salt solution, which
was used to prepare VBME medium contained 10 g of magnesium
sulfate, 100 g of citric acid monohydrate, 500 g of
potassium phosphate dibasic anhydrous, and 175 g of sodium
ammonium phosphate dissolved in 600 ml of deionized (DI)
water at 45°C.  After filtration through Whatman #1 flter
paper, the solution was autoclaved for 20 min at 121°C.
Dextrose solution (30%) for the VBME medium contained
30 g of dextrose dissolved in 1000 ml of DI water.  The
solution was autoclaved for 20 min at 121°C.
The histidine/biotin solution (0.5mM) used in the VBME
medium contained 97.6 mg of D-biotin and 52.5 mg of L-
histidine dissolved in 1000 ml of DI water.  The solution
was sterilized by filtration through a 0.45-Min filter
(Millipore, Bedford, MA).
The magnesium chloride/potassium chloride solution for
use in the 89 mix contained 40.7 g of magnesium chloride and
61.5 g of potassium chloride dissolved in 1000 ml of DI
water.  The solution was autoclaved for 20 min at 121°C.
The phosphate buffer (0.2M, pH 7.4) for use in the 89
mix contained 60 ml of a solution containing 13.8 g of
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sodium phosphate dibasic dissolved in 500 ml of DI water and
440 ml of a solution containing 14.2 g of sodium phosphate
monobasic dissolved in 500 ml of DI water.  The pH of the
solution was adjusted to 7.4 using NaOH or HCl.  The
solution was autoclaved for 20 min at 121''C.
3.1.3 Medium
VBME medium was prepared by dissolving 45 g of Bacto-
agar (Difco) in 2655 ml of DI water with heating.  The agar
mixture was autoclaved for 20 min at 121°C.  Then, 200 ml of
a 30% sterile dextrose solution was poured aseptically into
the liquid agar.  After the mixture cooled to 48°C, 60 ml of
sterile VBME 5OX salt solution was added, followed by 30 ml
of 0.5 mM histidine/biotin solution.  The agar solution was
stirred and dispensed into sterile 100- x 15-mm plastic
Petri dishes using an automatic plate pourer (-30 ml/dish).
Top agar was prepared by dissolving 6 g of Bacto-agar
and 5 g of sodium chloride in 1000 ml of DI water.
Approxiately 2.5 ml were dispensed into 13- x 100-mm glass
tubes, which were then capped and autoclaved for 20 min at
121°C.
3.2 Bacterial strain
Salmonella tvphimurium TA98 fhisD3052. rfa. uvrB,
pKMlOl) was kindly donated by Dr. B.N. Ames, Biochemistry
Department, University of California, Berkeley, CA.  The
strain was checked for the appropriate genetic markers and
background mutant yields each time a master plate was
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prepared (approximately every three weeks). The stock
cultures were maintained at -80°C in 9% DMSO.  Master plates
were used to establish overnight cultures.
3.3 Preparation of 89 Nix
Several different concentrations (9%, 18%, and 27%) of
S9 mix were used in this study.  In all cases, the method of
Maron and Ames, (1983) was followed.  A 1-ml solution of 9%
S9 mix contained 0.02 ml of magnesium chloride/potassium
chloride solution, 0.5 ml of phosphate buffer, 1.41 mg of
glucose-6-phosphate and 3.06 mg of nicotinamide adenine
dinucleotide phosphate in 0.39 ml of DI water, and 0.09 ml
of S9.  The solutions of S9 mix with higher concentrations
of S9 were prepared by increasing proportionally the volume
of S9, and mass of G-6-P and NADP, while decreasing the
volume of DI water.  The S9 mix was prepared using cold
ingredients and was maintained on ice for the duration of
the experiment.
3.4 Sources of Complex Mixtures
Main stream cigarette smoke condensate was a gift of
Dr. Gary Garola, Institute for Tobacco and Health Research,
Lexington, KY.  A cigarette smoking machine was used to
collect the particulate- and vapor-phase components of lit
Kentucky 2R1 reference cigarettes by pulling puffs of air
through the unlit end under standard conditions (Brunnemann
et al., 1976).  The condensate was extracted from the
filters with DMSO.
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Particle emissions from a diesel-powered fork lift were
collected from within the exhaust pipe and provided by M.
Wright, Donaldson Co., Minneapolis, MN.  The particles were
extracted with DCM by R. Williams (EHRT, Durham, NC) and
solvent exchanged into DMSO.  The percentage extractable
organic mass (EOM) was 2.33%.  The sample was provided by
Dr. Joellen Lewtas, U.S.EPA, RTP, NC.
Emissions from the incineration of polyethylene pipes
in a prototype/laboratory scale rotary kiln were generated
as described by Linak, et al. (1987) and collected as
described by Lemieux, et al. (1990)  The sample was
extracted with DCM and solvent exchanged into DMSO.  It
contained 8.42% EOM and was provided by Dr. David DeMarini,
U.S.EPA, RTP, NC.
Wood-preserving waste collected from a sediment pond of
a factory that used pentachlorophenol and creosote has been
described previously (Donnelly et al., 1987) and was a gift
of Dr. Kirby C. Donnelly, Soil and Crop Science Deptartment,
Texas A&M University, College Station, TX.  The waste was
extracted with DCM and had an EOM of 37.9%.
3.5 Spiral Salmonella Assay
3.5.1 Preparation
The spiral Salmonella Assay was performed as described
by Houk et al (1989).  An overnight culture (1-2 X 10^
cells/ml) of strain TA98 was grown by inoculating 20 ml of
sterile nutrient broth with a single colony from a master
- 3S-*5»";v'^^^^^t'>-"'"" ͣ'
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plate and incubating in a shaker incubator at 37'C, 110 rpm
for 16 h.  A 2OX concentration of cells was made by
centrifuging the overnight culture, pouring off the
supernatant, and resuspending the cells in 0.015 M phosphate
buffer.  VBME plates were warmed overnight in an incubator.
Stock solutions of the test chemicals, complex mixtures, and
controls were prepared in DCM or DMSO.
3.5.2 Performance of the Spiral Salmonella Assay
The spiral Salmonella assay was performed using the
spiral plater Model DU (Spiral System Instruments, Inc.,
Bethesda, MD).  The machine deposits the bacterial cell
concentrate, compound(s) to be tested, and S9 mix onto a
VBME plate.  A syringe expells each liquid through a Teflon
stylus resting on the surface of the agar plate as the plate
is being rotated.  The stylus travels from the center of the
plate to the edge, tracing a spiral in which the distance
between the whorls at right angles is constant.
The plater has two cams that drive the syringe to
expell a liquid.  One is a uniform cam that delivers a
constant volume of liquid throughout the spiral track.  The
second is the variable cam, which delivers a logarithmically
decreasing volume of liquid from the begining of the spiral
to the end.  The uniform cam was used to deposit the
bacteria and the variable cam was used to deposit the S9
mix.  Both cams were used to deposit the pure compound or
complex mixture.  The order of deposition onto the plate
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occurred as follows: (1) DCM or compounds dissolved in DCM,
(2) bacterial concentrate, (3) DMSO or compounds dissolved
in DMSO, and (4) S9 mix.
3.5.3 Counting Spiral Plates
The plates generated in the spiral Salmonella assay
were counted on a laser colony counter (Model 500A) obtained
from Spiral System Instruments, Inc. (Bethesda, MD).  The
plates were scanned with a single-wavelength, one-way laser
beam that detects reductions in light transmission when
passing over a colony.  The laser beam moves from the
periphery of the plate to the center in a series of 500
overlapping spirals.
3.5.4 Computerized Data Acquisition
An IBM personal computer (Model AT) was interfaced with
the plate counter.  SALS, a software program from Spiral
System Instruments, Inc., analyzes the data from the counter
and calculates the dose delivered by the variable cam based
on the known stock concentration.  The program determines
the number of colonies in each spiral and extrapolates these
counts to equivalent pour plate values.
3.6 Salmonella/Microsome Plate-Incorporation Assay
3.6.1 Performance of the Plate-Incorporation Assay
The plate-incorporation assay was performed as
described in Maron and Ames (1983).  Three concentrations
(9%, 18%, and 27%) of 59 mix (described above), dilutions of
the test chemical and control compounds, and an overnight
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culture of TA98 were prepared.  The bacterial culture (100
fj.1) ,   100 fil  of test chemical dissolved in DMSO, and 500 /nl
of S9 mix were added to a tube containing -2.5 ml of molten
top agar (46°C).  The tube was vortexed and the contents
were poured over the surface of a VBME plate.  The top agar
was allowed to harden, and the plates were inverted and
incubated in darkness at SVC for 72 h.  DMSO (100 /il/plate)
served as the negative control.  The positive controls were
2-nitrofluorene (3 /ig/plate) and 2-anthramine (0.5 /Ltg/plate)
in the absence and presence of S9, respectively.
3.6.2 Counting Plate-Incorporation Assay Plates
The plates were scored for revertants on the same
counter as that used for the spiral plates.  A different
program, SALP, also by Spiral Systems, Inc., corrects the
counts due to colony overlap.  The output is a single
revertant count for each plate.
3.7 Statistical Analysis
The additivity assumption was tested by fitting linear
models to the revertants counts.  Models fit were of the
form:
where A4da,Db ^^ ^^® expected number of revertants at dose D^
of chemical A and dose Dg of chemical B, Mq is the number of
revertants in negative controls, /liq^ and Mdb ^^^ "^^^
expected number of additional revertants observed at doses
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of chemicals A or B alone, and <Sj)^j)g quantifies the
deviation from a purely additive response.  If the response
to the exposure of a combination of chemicals is purely
additive, we would expect all of the Ss  to be zero.
The spiral assay data were analyzed using the
generalized estimating equation approach of Liang and Zeger
(1986) to fit the model (to account for the correlations
among responses in this setup), and models were fit to
plate-incorporation assay data using generalized linear
models (McCullagh and Nelder, 1989).  In each case, the
standard deviation was assximed to be proportional to the
mean.  Tests on the resulting parameter estimates were
performed using generalized Wald tests (Rotnitzky and
Jewell, 1990).
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4.0 RESULTS
4.1 Controls
The background mutant yield for TA98 in the spiral
assay ranged from 20 to 48 revertants/plate without S9 and
from 40 to 79 revertants/plate with S9.  In the plate-
incorporation assay, the background mutant yield for TA98
ranged from 36 to 45 revertants/plate without S9 and from 37
to 68 revertants/plate with S9.  The appropriate positive
controls were used in each experiment.  The negative and
positive control values were similar to historical control
values for the laboratory.
4.2 Experimental Design
Several different experimental schemes were used in the
spiral assay to assess the effect of binary combinations of
the pure compounds and complex mixtures.  First, a dose
range of the direct-acting mutagens INP, DE, and MX were
assayed separately and in pairs.  Second, all possible
binary combinations of the indirect-acting mutagens were
assayed at four different doses with the exception of PCP,
which was assayed at two doses.  The S9 mix, which was twice
the standard concentration used in the spiral assay, was
deposited with the variable cam, which produced a
concentration range of S9, because the unifoirm cam does not
expell an adequate volume of S9 mix.  Third, dose ranges of
4AB and BAP were also tested with a range of S9
concentrations with twice as much S9 being deposited for the
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binary mixture than for the single applications of 4AB and
BAP.
The piate-incorporation assay was used to compare the
results of binary combinations of mutagens produced in the
spiral assay to those produced by the more widely used
Salmonella mutagenicity assay. A dose range of the three
direct-acting mutagens and their binary combinations were
tested in the plate-incorporation assay.  The indirect-
acting mutagens were evaluated in this assay using several
doses and three levels of S9 concentrations of 1560, 3110,
and 4670 /ig of protein/plate (9%, 18%, and 27% S9) .
4.3 Treatment and Analysis of Data
Analysis of all the data points collected was not
attempted for various reasons.  Generally, both compounds in
a pair had to exhibit a concurrent response in the linear
portion of their dose response curves to be included in the
statistical analysis because the analysis of nonmutagenic or
toxic doses does not aid in determining additivity of the
mutagenic response.  Those combinations in which one
compound was active and the other was inactive at a given S9
concentration were not analyzed.  In all cases, to observe
the treatment effect, the background mutant yield was
subtracted from the responses of the single compounds and
their binary mixtures.  The results of the spiral assays
represent two pooled experiments, but the data from the
plate assays represent individual experiments.
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The statistical interpretation is footnoted in each
table.  The Wald test for additivity, which is distributed
as a Chi square distribution, the P values, and the
interpretation are shown.  Ninety-five percent confidence
intervals were used.  Because the test is not two-sided,
only additivity or nonadditivity can be determined
statistically.  However, if the majority of the Ss  are
greater than or less than zero, then one concludes that
there is an overall superadditive or subadditive effect,
respectively, and this result is expressed in parentheses in
the following tables.  The following discussion concerns the
statistical interpretation of the results.
4.4 Direct-Acting Mutagen Combinations
The data for the direct-acting mutagen combinations
tested in the spiral assay are presented in Tables 1-3.
None of the combinations were additive, but they were much
closer to exhibiting additive responses than were the binary
combinations of indirect-acting mutagens (see below).
Combinations of MX + DE and DE + INP were nonadditive
overall with additive responses at the lower doses.  The MX
and INP pair response was negatively nonadditive at the low
doses and positively nonadditive at the high doses.
4.5 Indirect-Acting Mutagen Combinations
The data for the indirect-acting mutagen combinations
tested in the spiral assay are shown in Tables 4-30.  It
should be noted that the data from the combinations of 4AB +
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PE, BAP + CSC, and CSC + PE were not analyzed because the
mutagenic responses of 4AB and CSC occurred at different
concentrations of S9 than those of BAP and PE (Fig. 2).
4.5.1 4AB + CSC Combination
The combination of 4AB + CSC produced negative
nonadditive effects for all four doses tested (Tables 4-7).
Overall, the degree of nonadditivity increased as the doses
of 4AB + CSC increased and as the concentration of S9
protein per plate increased.
4.5.2 4AB +  WPW Combination
4AB + WPW in combination yielded a negative nonadditive
response (Tables 8-11).  This response was observed at the
four doses of chemical and complex mixture tested.  As S9
concentration increased, there was a concurrent increase in
the negative deviation from an additive response.
4.5.3 BAP + WPW Combination
The binary combination of BAP + WPW elicited a negative
nonadditive response at all the doses tested (Tables 12-15).
The degree of deviation from additivity increased as the S9
concentration increased.
4.5.4 PE + WPW combination
The combination of PE + WPW produced negative
nonadditive effects for all four doses of chemical or
complex mixture tested (Tables 16-19). Overall
nonadditivity increased as the doses of PE + WPW increased.
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The degree of nonadditivity increased as the concentration
of S9 protein per plate increased.
4.5.5 BAP -I- PE Combination
Combinations of the lowest dose of BAP + PE produced an
additive response (Table 20).  However, the three highest
doses of BAP + PE elicited negative nonadditive effects
(Tables 21).  The degree of nonadditivity in the three
highest doses of the pair increased as the S9 concentration
increased.
4.5.6 CSC + WPW Combination
The binary combination of CSC + WPW yielded negative
nonadditive responses at all doses analyzed (Tables 24-26).
The deviation from additivity was proportional to the
increase in S9 concentration.
4.5.7 4AB + BAP Combination
The low dose of 4AB + BAP in combination produced an
additive response (Table 27).  However, the high dose of the
two compounds elicited a slight but statistically
significant positive nonadditive response (Table 28).  The
testing scheme in which twice the S9 concentration was being
delivered to the combination than to the single compounds
also produced an additive response from 4AB + BAP (Table
29) .
4.6 Indirect-Acting Mutagens with the Nonmutagen PCP
The data for the binary mixtures of PCP and other
indirect-acting mutagens are presented in Tables 30-34.
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Because PCP is not mutagenic in TA98, one might expect an
additive response unless there were synergistic or
antagonistic interactions occurring between the exogenous
activation and the chemicals or between the two compounds.
PCP exerted a negative nonadditive effect with 4AB, WPW, and
CSC.  The combination of PCP + BAP produced an additive
effect, and PCP + PE together produced a statistically
significant positive nonadditive effect.  However, visual
examination of the data indicate that if PCP is comutagenic
with PE, it exerts only a slight comutagenic effect.
4.7 Direct-Acting Mutagen Combinations in the Plate-
Incorporation Assay
The data for the direct-acting mutagen combinations
tested in the plate assay are presented in Tables 35-40.  In
general, the low doses of the paired compounds or complex
mixtures produce an additive response.  The results of the
two experiments of the MX + INP combination did not agree
statistically (Tables 35, 38).  The first experiment was
additive while the second was nonadditive.  However, there
was an additional high dose in the second experiment that
probably causes a nonadditive result in this case.
The combination of DE + INP also did not produce
statistically similar results in the two experiments (Tables
36, 39).  The dose responses of the combination in both
experiments were additive until the last dose in the second
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experiment where the response to the high dose was
nonadditive.
MX + DE in combination yielded statistically
nonadditive responses in both experiments (Tables 37, 40).
The three low doses elicited additive responses, but there
was a siginificant positive nonadditive response at the two
highest doses.
4.8 Indirect-Acting Mutagen Combinations in the Plate-
Incorporation Assay
The data for the binary combinations of 4AB + PE, BAP +
PE, and 4AB + BAP are shown in Tables 41-46, 47-52, and 53-
58, respectively.  The chemicals or complex mixture were
assayed in pairs with three concentrations of S9 mix (9%,
18%, and 27%).
4.8.1 4AB -I- PE Combination
The combination of 4AB and PE yielded overall
subadditive responses for the dose range tested in all three
S9 concentrations (Tables 41-46). However, at 18% and 27%
S9 concentrations, additive effects were observed at the low
doses of 4AB + PE (Tables 42, 43, 45, 46).  Within each S9
concentration, the deviation from additivity increased with
the increase of the dose of 4AB + PE.
4.8.2 BAP 4- PE Combination
The combination of BAP and PE produced an overall
subadditive response at the 9% S9 concentration (Tables 47,
50), but an additive overall response at 18% and 27% S9
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concentrations (Tables 48, 49, 51, 52).  At 9% S9 the
deviation from additivity increased as the dose of BAP and
PE increased, but this effect was not observed at 18% and
27% S9.
4.8.3 4AB + BAP Combination
4AB + BAP produced a nonadditive negative response at
9% S9 concentration (Tables 53, 56).  However, the pair
elicited additive responses over the entire dose range at
18% and 27% S9 (Tables 54, 55, 57, 58).  In all cases, the
increasing doses of chemical were paralleled by an
increasingly negative nonadditive response.
4.9 Summary of Results
Tables 59 and 60 provide a summary of results from the
spiral and plate-incorporation assays.  While the direct-
acting compounds did not yield statistically additive
responses at the 95% confidence level, I have used visual
examination of the dose response curves and professional
judgement to determine that these binary combinations
produce essentially additive responses.  The overall results
for the indirect-acting compounds in the spiral assay are
averages of the responses to the four doses used for the two
compounds.
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Table  1.
MX + INP Combination", Spiral Assay                          |
dose (jug/plate) net revertants/plate          |
MX INP MX INP MX+INP S
0.14 0.03 242 306 708 160
0.18 0.04 429 446 965 90
0.23 0.05 635 543 1246 68
0.30 0.06 694 915 1509 -100
0.39 0.08 762 1232 1873 -121
0.51 0.10 1189 1670 2328 -531#     !
*Wald test:   22.4;   P=0.0010;  nonadditive   (subadditive).
#  indicates  -1.96>Zo_95>1.96.
Table  2.
1 DE + INP Conibination'', Spiral Assay                          |
1  dose (/ig/plate) net revertants/plate          |
DE INP DE INP DE+INP s               1
0.14 0.03 106 228 357 23
0.18 0.04 156 299 528 73       1
0.23 0.05 195 325 770 250#
0.30 0.06 239 636 1003 128
0.39 0.08 318 868 1158 -28
0.51 0.10 419 1090 1761 252
0.68 0.14 631 1626 2308 51       1
*Wald test: 30.5; P<0.001; nonadditive (superadditive).
# indicates -1.96>Zo.95>1.96.
Table 3.
MX + DE Combination", Spiral Assay
dose ing) net revertants             |
MX DE MX DE MX+DE S
0.18 0.18 428 108 486 -50
0.23 0.23 634 142 832 56
0.30 0.30 692 218 1042 132
0.39 0.39 760 263 1218 195#
0.51 0.51 1186 391 1542 -35
*Wald test: 15.3; P=0.0090; nonadditive (superadditive).
# indicates -1.96>Zq95>1.96.
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Table 4.
4AB (40 jLtg/plate) + CSC (150 /xg/plate)*. Spiral Assay
S9 protein
(Mg/plate)
net revertants/plate
4AB CSC 4AB+CSC S
216.7 45 11 48 -8
278.6 105 65 111 -59
360.0 151 112 135 -128#
467.8 200 126 227 -99
611.8 417 169 316 -270#
807.6 472 141 432 -181#
*Wald test:   44.2;  P<0.0001;  nonadditive   (subadditive).
# indicates -1.96>Zo,95>1.96.
Table 5.
4AB (50 /ig/plate) + CSC (256 jug/plate)*, Spiral Assay
S9 protein
(/ig/plate)
net revertants/plate
4AB CSC 4AB+CSC S
216.7 91 45 40 -96#
278.6 63 45 87 -21
360.0 186 68 154 -100#
467.8 301 157 199 -259#
611.8 440 173 321 -292#
807.6 451 232 495 -188#
*Wald test: 69.8; P<0.0001; nonadditive (subadditive).
# indicates -1.96>Zq95>1.96.
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Table 6,
4AB (70 Mg/Plate) + CSC (338 /ig/plate)*, Spiral Assay
S9 protein
(Mg/plate)
net revertants/plate
4AB CSC 4AB+CSC S
216.7 108 -6 34 -68#
278.6 158 53 77 -134#
360.0 232 49 122 -159#
467.8 319 152 247 -224#
611.8 449 268 359 -358#
807.6 502 207 477 -232#
*'Wald test: 71.9; P<0.0001; nonadditive (subadditive)
# indicates -1.96>Zo,95>1.96.
Table 7.
4AB (90 Mg/plate) + CSC (440 /ig/plate)*, Spiral Assay
S9 protein
(jug/plate)
net revertants/plate
4AB CSC 4AB+CSC S
216.7 32 37 38 -31
278.6 107 36 47 -96#
360.0 228 101 79 -250#
467.8 339 134 179 -294#
611.8 477 194 336 -335#
807.6 596 348 397 -547#
*Wald test: 136.3; P<0.0001; nonadditive (subadditive).
# indicates -1.96>Zo95>1.96.
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Table 8
4AB (40 /xg/plate) + WPW (150 /xg/plate)*. Spiral Assay
S9 protein
(jug/plate)
net revertants/plate
4AB WPW 4AB+WPW S
132.8 33 26 21 -38#
169.4 64 18 -3 -85#
216.7 166 52 72 -146#
278.6 205 65 100 -170#
360.0 314 123 143 -294#
467.8 583 105 136 -552#
611.8 637 70 181 -526#
807.6 822 52 179 -695#
*Wald test: 344.5; P<0.0001; nonadditive (subadditive).
# indicates -1.96>Zq95>1.96.
Table 9.
4AB (50 jug/plate) + WPW (256 Mg/plate)*, Spiral Assay
S9 protein
(/xg/plate)
net revertants/plate
4AB WPW 4AB+WPW S
104.5 10 9 33 14
132.8 49 34 24 -59#
169.4 47 34 10 -71#
216.7 138 17 63 -92#
278.6 212 55 32 -235#
360.0 405 113 95 -423#
467.8 541 139 123 -557#
611.8 758 98 151 -705#
807.6 970 124 214 -880#
1052.0 1063 143 213 -993#
*Wald test: 1483.2; P<0-0001; nonadditive (subadditive)
# indicates -1.96>Zq95>1.96.
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Table 10.
4AB (70 /ig/plate) + WPW (338 /ig/plate)*, Spiral Assay
S9 protein
(/ig/plate)
net revertants/plate
4AB WPW 4AB+WPW S
169.4 42 39 9 -72#
216.7 115 26 58 -83#
278.6 264 119 99 -284#
360.0 362 66 177 -251#
467.8 602 83 138 -547#
611.8 755 128 213 -670#
807.6 890 134 254 -770#
1052.0 1037 132 240 -929#
*Wald test: 411.8; P<0.0001; nonadditive (subadditive).
# indicates -1.96>Zo.95>1.96.
Table 11.
4AB (90 /ig/plate) + WPW (440 Mg/Plate)*, Spiral Assay
S9 protein
(Mg/plate)
net revertants/plate
4AB WPW 4AB+WPW S
104.5 12 12 -12 -36
132.8 21 1 0 -22
169.4 48 2 -8 -58#
216.7 140 40 43 -137#
278.6 166 60 28 -198#
360.0 272 29 110 -191#
467.8 376 -7 28 -341#
611.8 524 44 76 -492#
807.6 576 75 133 -518#
1052.0 676 55 149 -582#
indicates -1.96>Zo95>1.96.
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Table  12,
BAP (0.4 /ig/plate) + WPW (150 /ig/plate)*. Spiral Assay
S9 protein
(/ig/plate)
net revertants/plate
BAP WPW BAP+WPW S
82.4 54 49 36 -67#
104.5 80 46 39 -87#
132.8 80 26 9 -97#
169.4 124 18 53 -89#
216.7 93 52 56 -89#
278.6 157 65 72 -150#
*Wald test:   259.8;  P<0.0001;   nonadditive   (subadditive).
#  indicates  -1.96>Zo95>1.96.
Table  13
BAP (0.5 /ig/ plate) + WPW (256 /ig/plate)*. Spiral Assay
S9 protein
(/ig/plate)
net revertants/plate
BAP WPW BAP+WPW S
82.4 45 61 43 -63#
104.5 70 9 21 -58#
132.8 76 34 52 -58#
169.4 147 34 18 -163#
216.7 131 17 63 -85#
278.6 161 55 44 -172#
360.0 182 113 73 -222#
*Wald test: 176.7; P<0.0001; nonadditive (subadditive).
# indicates -1.96>Zo,95>1.96.
49
Table 14,
BAP (0.7 Mg/Plate) + WPW (338 Mg/plate)*, Spiral Assay
S9 protein
(Mg/plate)
net revertants/plate
BAP WPW BAP+WPW S
82.4 98 63 48 -113#
104.5 75 9 15 -69#
132.8 122 16 11 -127#
169.4 102 39 2 -139#
216.7 252 26 44 -234#
*Wald test: 145.6; P<0.0001; nonadditive (subadditive)
# indicates -1. 96>Zq 95>1.96.
Table 15.
BAP (0.9 Mg/ plate) + WPW (440 /xg/plate)*, Spiral Assay
S9 protein
(jLig/plate)
net revertants/plate
BAP WPW BAP+WPW S
104.5 71 12 14 -69#
132.8 84 1 18 -67#
169.4 134 2 8 -128#
216.7 216 40 35 -221#
278.6 244 60 43 -261#
360.0 149 29 49 -129#
*Wald test: 75.5; P<0.0001; nonadditive (subadditive).
# indicates -1.96>Zo95>1.96.
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Table  16.
PE (4 Mg/Plate) + WPW (150 ^g/plate)*. Spiral Assay
S9 protein
(iug/plate)
net revertants/plate
PE WPW PE+WPW S
82.4 242 49 47 -244#
104.5 341 46 10 -377#
132.8 433 26 42 -417#
169.4 512 18 59 -471#
216.7 505 52 83 -474#
278.6 646 65 105 -606#
*Wald test:   804.9;  P<0.0001;  nonadditive   (subadditive).
# indicates -1.96>Zo_95>1.96.
Table  17.
PE (6 jug/plate) + WPW (.256 jug/plate)*. Spiral Assay
S9 protein
(jug/plate)
net revertants/plate
PE WPW PE+WPW S
82.4 329 61 76 -314#
104.5 407 9 40 -376#
132.8 734 34 19 -749#
169.4 818 34 36 -816#
216.7 935 17 47 -905#
*Wald test: 603.4; P<0.0001; nonadditive (subadditive).
# indicates -1.96>Zo95>1.96.
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Table  18,
PE (10 /xg/plate) + WPW (338 ^g/plate)". Spiral Assay
S9 protein
(Mg/plate)
net revertants/plate
PE WPW PE+WPW S
82.4 273 63 71 -265#
104.5 497 9 7 -499#
132.8 821 16 30 -807#
169.4 790 39 40 -789#
216.7 1115 26 76 -1065#
*Wald test:   1157.1;  P<0.0001;  nonadditive   (subadditive).
#  indicates  -1.96>Zo.95>1.96.
Table  19,
PE (20 /xg/plate) + WPW (440 /ig/plate)*'. Spiral Assay
S9 protein
(jug/plate)
net revertants/plate
PE WPW PE+WPW S
82.4 184 34 59 -159#
104.5 314 13 37 -290#
132.8 468 2 37 -433#
169.4 695 3 49 -649#
216.7 1047 41 80 -1008#
278.6 1358 61 109 -1310#
*Wald test: 75.4; P<0.0001; nonadditive (subadditive).
# indicates -1.96>Zo.95>1.96.
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Table 20.
BAP (0.4 /ig/plate) + PE (4 /xg/plate)*. Spiral Assay
S9 protein
(jug/plate)
net revertants/plate
BAP PE BAP+PE S
82.4 52 67 83 -36
104.5 61 127 162 -2 6
132.8 34 233 231 -36
169.4 67 337 350 -54
216.7 71 398 473 4
278.6 167 419 627 41
*Wald test: 6.5; P=0.3740; additive (additive)
Table 21.
BAP (0.5 /xg/ plate) + PE ( 6 jitg/plate)". Spiral Assay
S9 protein
(/xg/plate)
net revertants/plate
BAP PE BAP+PE S
82.4 0 85 118 33
104.5 7.5 155 130 -33
132.8 39 340 277 -102#
169.4 76 486 449 -113
216.7 78 697 636 -139#
278.6 127 801 674 -254#
*Wald test: 42.7; P<0.0001; nonadditive (subadditive)
# indicates -1.96>Zo.95>1.96.
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Table  22
BAP (0.7 jug/plate) + PE (10 ^g/plate)*. Spiral Assay
S9 protein
(/xg/plate)
net revertants/plate
BAP PE BAP+PE S
82.4 25 159 107 -77
104.5 -4 219 195 -20
132.8 37 340 376 -1
169.4 110 517 435 -192#
216.7 159 765 736 -188
278.6 242 929 895 -276#
*Wald test:   14.8;  P=0.0219;  nonadditive   (subadditive).
#  indicates  -1.96>Zo95>1.96.
Table 23.
BAP (0.9 /xg/plate) + PE (20 /xg/plate)*. Spiral Assay
S9 protein
(/xg/plate)
net revertants/plate
BAP PE BAP+PE 6
82.4 11 191 242 40
104.5 48 346 299 -95#
132.8 32 459 360 -131#
169.4 57 650 681 -26
216.7 142 880 880 -142#
278.6 186 1182 1132 -236#
360.0 146 1387 1425 -108
*Wald test: 60.0; P<0.0001; nonadditive (subadditive)
# indicates -1.96>Zo.95>1.96.
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Table 24.
CSC (150 Mg/Plate) + WPW (150 Mg/plate)", Spiral Assay
S9 protein
(^g/plate)
net revertants/plate
CSC WPW CSC+WPW S
216.7 11 14 38 13
278.6 65 73 57 -81#
360.0 112 106 80 -138#
467.8 126 125 90 -161#
611.8 169 143 94 -218#
*Wald test: 188.5; P<0.0001; nonadditive (subadditive)
# indicates -1.96>Zo_95>1.96.
Table 25.
CSC (256 fig/ plate) + WPW (256 Mg/plate)", Spiral Assay
S9 protein
(Mg/plate)
net revertants/plate
CSC WPW CSC+WPW S
132.8 -9 22 24 11
169.4 -11 31 15 -5
216.7 45 31 58 -18
278.7 45 62 50 -57#
360.0 68 86 94 -60#
467.8 157 99 144 -112#
*Wald test: 45.0; P<0.0001; nonadditive (subadditive).
# indicates -1.96>Zo 95>1.96.
Table 26.
CSC (338 jug/ plate) + WPW (338 /xg/plate)". Spiral Assay
S9 protein
(/xg/plate)
net revertants/plate
CSC WPW CSC+WPW 6
132.8 11 21 36 4
169.4 23 26 -6 -55#
216.7 -6 61 45 -10
278.6 53 49 43 -59#
360.0 49 44 87 -6
467.8 152 49 81 -120#
611.8 268 104 195 -177#
*Wald test: 73.4; P<0.0001; nonadditive (subadditive).
# indicates -1.96>Zo 95>1.96.
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Table 27.
4AB (40 /ig/plate) + BAP (0.4 /ug/plate)". Spiral Assay          |
S9 protein
(Mg/plate)
net revertants/plate
4AB BAP 4AB+BAP S
132.8 25 20 35 -10
169.4 49 23 88 16
216.7 44 86 134 4
278.6 69 98 204 37
*Wald test: 3.5; P=0.4811; additive (additive).
Table 28.
4AB (70 jug/plate) + BAP (0.7 /ig/plate)". Spiral Assay
S9 protein
(Mg/plate)
net revertants/plate
4AB BAP 4AB+BAP S
132.8 15 27 85 43
169.4 14 95 80 -29
216.7 79 93 211 39
278.6 77 155 261 29
*Wald test: 10.2; P=0.0368; nonadditive (superadditive)
Table 29.
4AB + BAP", Proportional S9, Spiral Assay
S9 protein
(Mg/plate)
dose
(Mg/plate)
net revertants/plate
mix (single) 4AB BAP 4AB BAP 4AB+BAP S
216.7 (108.4) 18.1 0.18 2 40 54 12
278.6 (139.3) 23.3 0.23 58 50 122 14
360.0 (180.0) 30.1 0.30 87 141 191 -37
467.8 (233.9) 39.1 0.39 149 134 278 -5
611.8 (305.9) 51.2 0.51 306 170 450 -26
807.6 (403.8) 67.6 0.68 394 226 673 53
*Wald test: 4.2; P=0.6518; additive (additive)
^i^^^^^^i.r'^f^^^' ^j^^fT
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Table 30.
4AB (90 jug/plate) + PCP (29.9 /ug/plate)*. Spiral Assay
S9 protein
(/xg/plate)
net revertants/plate
4AB PCP 4AB+PCP S
169.4 63 -31 57 25
216.7 111 -14 47 -50#
278.6 226 -22 210 6
360.0 389 -5 352 -32
467.8 527 -50 543 66
611.8 825 -42 713 -70
807.6 1033 7 788 -252
ͣwald test: 131.8; P<0.0001; nonadditive (subadditive).
# indicates -1.96>Zo.95>1.96.
Table 31.
BAP (0.9 ng/ plate) + PCP (29.9 /ig/plate)*. Spiral Assay
S9 protein
(Mg/plate)
net revertants/plate
BAP PCP BAP+PCP S
132.8 53 7 82 22
169.4 112 -19 138 45#
216.7 163 -5 194 36
278.6 222 -25 266 69
"Wald test: 6.8; P=0.1495; additive (additive)
# indicates -1.96>Zo,95>1.96.
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Table 32
CSC (440 /ig/ plate) + PCP (29.9 /ig/plate)*. Spiral Assay
S9 protein
(/ug/plate)
net revertants/plate
CSC PCP CSC+PCP S
169.4 5 -7 20 22
216.7 37 3 -6 -46#
278.6 36 -3 50 17
360.0 101 -12 76 -13
467.8 134 -2 95 -37
611.8 194 18 193 -19
807.6 348 29 328 -49
*Wald test: 27.4; P=0.0003; nonadditive (subadditive).
# indicates -1.96>Zo,95>1.96.
Table 33.
PCP (29.9 Mg/plate) + PE (20 ^g/plate)*. Spiral Assay
S9 protein
(Mg/plate)
net revertants/plate
PCP PE PCP+PE S
82.4 -11 267 315 59#
104.5 -2 404 420 18
132.8 7 539 706 160#
169.4 -19 906 1033 146#
216.7 -5 1311 1424 118
278.6 -25 1574 1936 387#
*Wald test: 41.7; P<0.0001; nonadditive (superadditive).
# indicates -1.96>Zo.95>1.96.
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Table  34.
PCP (29.9 /xg/plate) + WPW (440 /ig/plate)*, Spiral Assay
S9 protein
(/xg/plate)
net revertants/plate              i
PCP WPW PCP+WPW S
132.8 7 -18 -8 3
169.4 -19 -18 16 53
216.7 -5 9 -20 -24
278.6 -25 24 -3 -2
360.0 -23 68 19 -26
467.8 -16 56 18 -22
611.8 -43 57 53 39
807.6 44 71 133 18
1052.0 22 115 125 -12
*Wald test:   18.3;   P=0.0321;  nonadditive;   subadditive.
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Table 35.
MX + INP, Plate Assay, Experiment l"
dose (/ig/plate) net revertants/plate
MX INP MX INP MX+INP S
0.025 0.1 63 110 164 -9
0.05 0.2 169 290 459 0
0.1 0.3 393 407 894 94
0.2 0.4 1059 670 1885 156
''Wald test: 7.7; P=0.1021; additive; additive.
Table 36.
DE + INP, Plate Assay, Experiment 1*
dose (/jg/plate) net revertants/plate
DE INP DE INP DE+INP S
0.25 0.1 65 110 173 -2
0.75 0.3 213 407 661 41
1.0 0.4 315 670 1041 56
2.0 0.5 668 916 1612 28
"Wald test: 2.7; P=0.6100; additive; additive.
Table 37.
MX + DE, Plate Assay, Experiment 1*
dose (/xg/plate) net revertants/plate
MX DE MX DE MX+DE S
0.025 0.25 63 65 125 -3
0.05 0.5 169 144 323 10
0.1 0.75 393 213 671 65
0.2 1.0 1059 315 1519 145
0.25 2.0 1465 668 2395 262
ͣwald test: 12.7; P=0.0263; nonadditive; superadditive.
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Table 38.
MX + INP, Plate Assay, Experiment 2*
dose (/xg/plate) net revertants/plate
MX INP MX INP MX+INP S
0.025 0.1 64 144 208 0
0.05 0.2 144 298 428 -14
0.1 0.3 378 494 972 100
0.2 0.4 1027 704 1971 240
0.25 0.5 1542 1010 2795 243
*Wald test: 12.7; P=0.0268; nonadditive; superadditive.
Table 39.
DE + INP, Plate Assay, Experiment 2*
dose (/xg/plate) net revertants/plate
DE INP DE INP DE+INP S
0.25 0.1 78 144 197 -25
0.5 0.2 162 298 424 -36
0.75 0.3 271 494 751 -14
1.0 0.4 367 704 1056 -15
2.0 0.5 753 1010 1438 -325
*Wald test: 17.1; P=0.0043; nonadditive; subadditive.
Table 40.
MX + DE, Plate Assay, Experiment 2"
dose (Mg/plate) net revertants/plate
MX DE MX DE MX+DE S
0.025 0.25 64 78 110 -32
0.05 0.5 144 162 281 -25
0.1 0.75 378 271 664 15
0.2 1.0 1027 367 1586 192
0.25 2.0 1542 753 2493 198
'Wald test: 26.0; P<0.0001; nonadditive; superadditive
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Table 41.
4AB + PE, Plate Assay, 9% S9, Experiment 1*
dose (/ig/plate) net revertants/plate
4AB PE 4AB PE 4AB+PE S
10.0 4.0 211 102 210 -103
20.0 6.0 388 142 303 -227
40.0 10.0 690 264 474 -480
50.0 20.0 845 474 588 -731
*Wald test: 273.1; P<0.0001; nonadditive; subadditive.
Table 42.
4AB + PE, Plate Assay, 18% S9, Experiment 1*
dose (/Ltg/plate) net revertants/plate
4AB PE 4AB PE 4AB+PE S
10.0 4.0 195 72 272 5
20.0 6.0 423 104 520 -7
40.0 10.0 966 228 912 -282
50.0 20.0 1286 424 1039 -671
"Wald test: 65.3; P<0.0001; nonadditive; subadditive.
Table 43.
4AB + PE, Plate Assay, 27% S9, Experiment 1*
dose (jug/plate) net revertants/plate
4AB PE 4AB PE 4AB+PE S
10.0 4.0 159 57 201 -15
20.0 6.0 354 90 499 55
40.0 10.0 862 170 1067 35
50.0 20.0 1273 348 1306 -315
*Wald test: 10.9; P=0.0276; nonadditive; subadditive.
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Table 44,
4AB + PE, Plate Assay, 9% S9, Experiment 2*
dose (|ig/plate) net revertants/plate
4AB PE 4AB PE 4AB+PE S
10.0 4.0 192 58 172 -78
20.0 6.0 386 147 254 -279
40.0 10.0 621 217 370 -468
50.0 20.0 780 474 486 -768
70.0 30.0 816 584 645 -755
*Wald test: 263.8; P<0.0001; nonadditive; subadditive.
Table 45.
4AB + PE, Plate Assay, 18% S9, Experiment 2*
dose (/xg/plate) net revertants/plate
4AB PE 4AB PE 4AB+PE S
10.0 4.0 174 66 277 37
20.0 6.0 387 98 508 23
40.0 10.0 943 197 871 -269
50.0 20.0 1216 459 966 -709
70.0 30.0 1422 664 1106 -980
*Wald test: 86.3; P<0.0001;
Table 46.
nonadditive; subadditive.
4AB + PE, Plate Assay, 27% S9, Experiment 2"
dose (/ig/plate) net revertants/plate
4AB PE 4AB PE 4AB+PE S
10.0 4.0 150 56 223 17
20.0 6.0 375 81 557 101
40.0 10.0 965 165 1054 -76
50.0 20.0 1163 386 1209 -340
70.0 30.0 1640 550 1309 -881
^Wald test : 40.4; P<().0001; noiladditive; subadditi^/e.
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Table  47.
BAP + PE, Plate Assay, 9% S9, Experiment 1*
dose ()Lig/plate) net revertants/plate
BAP PE BAP PE BAP+PE S
0.5 4.0 64 121 178 -7
0.7 6.0 117 195 283 -29
0.9 10.0 144 334 382 -96
2.0 20.0 278 717 641 -354
3.0 30.0 436 965 961 -440
*Wald test:   48.4;   P<0.0001;   nonadditive;   subadditive.
Table  48.
BAP + PE, Plate Assay, 18% S9, Experiment 1*
dose (/xg/plate) net revertants/plate
BAP PE BAP PE BAP+PE S
0.5 4.0 39 74 153 40
0.7 6.0 53 135 221 33
0.9 10.0 90 216 371 65
2.0 20.0 216 570 776 -10
3.0 30.0 333 878 1189 -22
*Wald test:   10.2;   P=0.0697;   additive;   additive.
Table  49.
BAP + PE, Plate Assay, 27% S9 , Experiment 1*
dose (jug/plate) net revertants/plate
BAP PE BAP PE BAP+PE S
0.5 4.0 19 57 100 24
0.7 6.0 32 104 141 5
0.9 10.0 67 205 258 -14
2.0 20.0 130 549 622 -57
3.0 30.0 280 781 1030 -31
''Wald test. 4.3; P=0. 5074; addjLtive; addJLtive.
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Table 50.
BAP + PE, Plate Assay, 9% S9, Experiment 2*
dose (/xg/plate) net revertants/plate
BAP PE BAP PE BAP+PE S
0.5 4.0 54 58 160 48
0.7 6.0 66 147 227 14
0.9 10.0 134 217 371 20
2.0 20.0 239 474 600 -113
3.0 30.0 286 584 760 -110
*Wald test: 9.6; P=0.0885; additive; additive.
Table 51.
BAP + PE, Plate Assay, 18% S9, Experiment 2*
dose (jug/plate) net revertants/plate
BAP PE BAP PE BAP+PE S
0.5 4.0 18 66 108 24
0.7 6.0 33 98 172 41
0.9 10.0 57 197 283 29
2.0 20.0 207 459 610 -56
3.0 30.0 309 664 803 -170
*Wald test: 10.1; P=0.0736; additive; additive.
Table 52.
BAP + PE, Plate Assay, 27% S9 , Experiment 2*
dose (Mg/plate) net revertants/plate
BAP PE BAP PE BAP+PE s
0.5 4.0 5 56 82 21
0.7 6.0 33 81 136 22
0.9 10.0 38 165 238 35
2.0 20.0 108 386 660 166
3.0 30.0 181 550 774 43
''Wald test. 9.2; P=0. 1012; addjLtive; add]Ltive.
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Table  53.
4AB + BAP, Plate Assay, 9% S9, Experiment l"
dose (/xg/plate) net revertants/plate
4AB BAP 4AB BAP 4AB+BAP S
10.0 0.5 129 34 150 -13
20.0 0.7 290 55 297 -48
40.0 0.9 537 57 469 -125
50.0 2.0 603 132 461 -274
"Wald test: 27.1; P<0.0001; nonadditive; subadditive.
Table 54.
4AB + BAP, Plate Assay, 18% S9, Experiment 1*
dose ()ug/plate) net revertants/plate
4AB BAP 4AB BAP 4AB+BAP S
10.0 0.5 124 20 149 5
20.0 0.7 293 6 352 53
40.0 0.9 819 35 795 -59
50.0 2.0 1026 103 1029 -100
*Wald test: 3.2; P=0.5212; additive; additive.
Table 55.
4AB + BAP, Plate Assay, 27% S9, Experiment l"
dose (/Ltg/plate) net revertants/plate
4AB BAP 4AB BAP 4AB+BAP S
10.0 0.5 110 23 149 16
20.0 0.7 267 20 301 14
40.0 0.9 778 27 773 -32
50.0 2.0 1038 98 1105 -31
*Wald test:   0.9;  P=0.9210;   additive;   additive.
66
Table  56,
4AB + BAP, Plate Assay, 9% S9, Experiment 2"
dose (jLig/plate) net revertants/plate
4AB BAP 4AB BAP 4AB+BAP S
10.0 0.5 211 57 205 -63
20.0 0.7 388 109 394 -103
40.0 0.9 690 108 610 -188
50.0 2.0 845 275 629 -491
*Wald test: 82.9; P<0.0001; nonadditive; subadditive.
Table 57.
4AB + BAP, Plate Assay, 18% S9, Experiment 2*
dose (/xg/plate) net revertants/plate
4AB BAP 4AB BAP 4AB+BAP S
10.0 0.5 195 17 201 -11
20.0 0.7 423 61 473 -11
40.0 0.9 966 80 952 -94
50.0 2.0 1286 202 1266 -222
*Wald test: 6.2; P=0.1851; additive; additive.
Table 58.
4AB + BAP, Plate Assay, 27% S9, Experiment 2*
dose (/ig/plate) net revertants/plate
4AB BAP 4AB BAP 4AB+BAP S
10.0 0.5 159 18 183 6
20.0 0.7 354 36 385 -5
40.0 0.9 862 49 995 84
50.0 2.0 1273 142 1395 -20
"Wald test:   1.4;  P=0.8518;  additive;  additive.
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Table 59. Summary of Results, Spiral Assay
Spiral Assay
Combination   89   Additive   Subadditive
MX+1NP  
DE+NP  
DE + MX  
4AB + CSC +
4AB + WPW +
BAP + WPW +
PE + WPW +
BAP + PE +
CSC + WPW +
4AB + BAP +  
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Table 60. Summary of Results, Plate Assay
Plate-incorporation Assay
Combination %S9 Additive Subadditive
MX+1NP -  
DE + NP -  
DE + MX -  
4AB + BAP 9  
18  
27  
4AB + PE 9  
18  
27  
BAP + PE 9 inconclusive
18  
27  
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5.0 DISCUSSION
5.1 Direct-Acting Mutagens Exhibit Additive Responses
In the absence of S9, the mutagenic response of binary
combinations of agents in the spiral assay was statistically
nonadditive.  However, a less rigorous statistical method
than employed here and visual examination of the data would
indicate that the overall response was additive.  In fact,
statistically significant additive effects are observed at
the low doses tested.  The data for the same compounds in
the plate assay yield essentially the same result.
In both assays, the deviation from additivity increased
as the doses of the compounds and complex mixtures
increased.  This phenomenon could be explained for the
subadditive effects by crowding of revertants on the plate
at high doses, inhibiting colony formation.  However, this
does not explain the fact that the phenomenon also occurs in
superadditive effects.  Perhaps, then, the observed effects
are due to a slight synergism or antagonism occurring
between the two compounds, and the increasing dose of
compound magnifies the outcome.
Depending on the criteria for declaring additivity, the
assumption of additivity appears to be valid for most of the
mutagens studied here that do not require metabolic
activation.  Few direct-acting compounds have been tested in
binary combination.  Of these studies, only the combination
of ethyl methane sulfonate + MNNG (Salamone et al., 1979)
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and phenobarbitol + 4NQ0 (Albertini and Gocke, 1992)
produced an additive effect.
There is no doubt that there are direct-acting
chemicals that, in combination, may produce true
superadditive effects.  Hass et al (1987) and Thornton-
Manning et al (1989) demonstrated that isomers of
nitrobenzo(a)pyrenes produce superadditive effects in
Salmonella.  Nonetheless, our results suggest that the
additivity assumption may be reasonable for binary
combinations of direct-acting mutagens.
5.2 Indirect-Acting Mutagens Exhibit Nonadditive
Responses
In the presence of S9, the mutagenic response of binary
combinations of agents in the spiral assay was, with the
exception of the combination of 4AB and BAP, statistically
nonadditive, and the deviations from additivity were
predominantly negative.  From visual inspection of the data,
it is clear that most binary combinations of promutagenic
pure compounds and complex mixtures produce subadditive
results in the spiral assay.
Of the three combinations of promutagens tested in the
plate assay, the results of only one pair, 4AB and PE,
agreed with those in the spiral assay.  In the plate assay,
the binary combination of 4AB and BAP was subadditive, and
BAP and PE in combination yielded an additive result at 18%
and 27% S9.  Visual inspection of the data generally bear
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this out, although it should be recognized that the low
doses of agents are more likely to elicit additive responses
than are high doses.  The addition of more S9 in the plate
assay may induce an additive response in those binary
combinations of agents that tend to be subadditive at low
concentrations of exogenous metabolic activation.
The literature shows that nonadditivity occurs more
often than additivity in the plate-incorporation assay.
However, most of the nonadditive responses were
superadditive responses (Yoshida et al., 1979; Ogawa et al.,
1985; Ogawa et al., 1987; Crebelli et al., 1991; Whong et
al., 1989; and Albertini and Gocke, 1992) rather than
subadditive responses (Salamone et al., 1979; Crebelli et
al., 1991).  Several researchers have also noted the
phenomenon of different responses to the binary combination
depending on differing doses of the compounds (Hermann,
1981; Ogawa et al., 1985) or varying S9 concentrations
(Yoshida et al., 1979).  Thus, with few exceptions, the
additivity assumption does not apply to binary combinations
of indirect-acting mutagens in bacterial assays.
5.3 Exogenous Activation As a Confounding Factor
The variable amount of metabolic activation required by
each promutagen for maximum mutagenic response was a
confounding variable that complicates the interaction
studies of indirect-acting mutagens.  The results of the
plate assays generally showed that an increasing dose of the
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agents with a constant S9 concentration increased the
deviation from additivity.  In addition, when comparing the
same dose with the three different concentrations of S9, a
change in the degree of nonadditivity appeared.  These
results support the notion that the active sites of the
isozymes in the S9 mix may become saturated as more mutagen
is added to the system.
An interesting finding in the spiral assay is the
increase in the deviation from additivity with a constant
dose of the two agents as the concentration of S9 rises,
which does not agree with the results of the plate assay.
One would suppose that with a constant dose of mutagen(s)
increasing the amount of S9 in the spiral assay would, at
some point, provide enough metabolic capability so that the
response of both agents would be expressed.  However, this
was not borne out where this experimental design was used.
An explanation is that appropriate dose ranges of the single
compounds were determined using the same concentration of S9
as that used for the binary combinations.  Perhaps, there
was not enough metabolic capability remaining to metabolize
both compounds simultaneously to their reactive
intermediates.
5.4 Cellular Processes and Xenobiotic Compounds
There are a large number of steps and interactions that
occur that produce the final result in the studies reported
here.  Although the details of the mechanisms underlying
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subadditivity, additivity, or superadditivity are unknown,
some of the possible causes for these effects should be
considered.  Although the chemical interaction of two agents
added to the plate is certainly possible, depending on the
agents, such a chemical interaction seems generally unlikely
for the agents studied here and may play little role in
results reported here.  Most of the mutagenic species used
in this research are electrophiles that will not tend to
react with each other but with macromolecules present in the
medium (S9 protein) or on or in the cells.  Thus, direct
chemical interaction probably does not contribute to the
observed outcome.
Although cells have active transport mechanisms that
bring certain types of molecules into the cell, such systems
are unlikely to carry the mutagens studied here into the
cell.  Instead, passive diffusion, facilitated by the rfa
gene mutation that results in the loss of a portion of the
lipopolysaccharide layer of the cell wall—enhancing the
permeability of the cell wall to large molecules, is the
most likely mechanism for the entry of the mutagens studied
here into the cells.  Such a mechanism would not be expected
to be saturated by the presence of binary combinations of
mutagens or by complex mixtures of mutagens.  Thus, entry
into the cell is unlikely to account for the observed
results.
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Once the mutagens enter the cell, they may interact
with various macromolecules or be metabolized prior to such
interactions.  The role of S9 has been discussed previously;
and the limited number of forms of P450 may indeed be
saturated by the presence of multiple mutagens.  The
production of many electrophilic species (or simply the
uptake of several such species of direct-acting mutagens) is
followed by the binding of such compounds to macromolecules.
Because of the potentially high reactivity of such
agents, they may bind to proteins and nucleic acids.  An
important aspect of this may be nonspecific binding to
proteins.  Indeed, the subadditivity observed in the
presence of S9 may result from the prodction of large
amounts of electrophiles that then bind to the S9 protein
and are, thus, unavailable to interact with the DNA.  This
may be an important basis for the lack of additvity observed
in the present study for most combinations of indirect-
acting mutagens.
Interactions of the mutagens with either proteins or
nucleic acids could result in cytotoxicity, which could
clearly contribute to the subadditive effects observed in
this study. Although analysis of the mutagenic response was
performed using data from the initial linear portion of the
mutagenicity dose-response curves, cytotoxicity generally
occurs as a logrithmic function.  Thus, even relatively
small amounts of cytotoxicity could have a considerable
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impact on the mutagenicity results, because dead cells would
not produce revertants.  Although there was no reduction in
the thickness of the cell lawn on the plates as determined
visually, there could have been some reduction in cell
vability that could have contributed to the observed
results.
Although mutagens may have a preference for the types
of nucleotides to which they might bind, the large number of
nucleotides available in the cellular chromosome would be
sufficient to accommodate binding even of the many molecules
present in the binary mixtures used here.  Thus, saturation
of the DNA would be an unlikely mechanism to account for the
observed results.
Once the mutagens have bound to the DNA, DNA repair
mechanisms may then try to eliminate or correct the damage.
Although the cells used in the present study were lacking
DNA nucleotide excision repair, they contained other DNA
repair processes such as mismatch repair and proofreading
functions of the DNA polymerase.  It is possible that some
of these repair processes could have become saturated,
particularly at the higher dose levels of mutagens,
resulting in the subadditivity observed in the present
study.  However, the finding of additivity (or statistical
superadditivity) with the combinations of direct-acting
mutagens suggests that this is not likely.  Instead, DNA
repair processes may have repaired equally well the
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different types of damage produced by the variety of
mutagens to which the cell was exposed simultaneously.
Finally, one must consider the various mutational
pathways by which the different agents studied here result
in mutations that are suitable to produce a revertant.  The
mutation spectra for some agents used in this study have
been determined.  Although the mutational spectra for MX,
4AB, BAP, and INP share some similarities, they also contain
sites or types of mutations that are unique to each agent
(Bell et al., 1991; DeMarini et a., 1993; Levine et al.,
submitted; DeMarini, unpublished observations).
Nonetheless, a preliminary consideration of the role of
mutational pathways suggests that they may not interfere
with the achievement of additivity—at least for the direct-
acting mutagens.  They also may not account for the
subadditive results obtained with the indirect-acting
mutagens, which may be due more to the nonspecific binding
of electrophiles to the S9 protein.
5.5 Binary Combinations with a Comutagen
PCP does not appear to be comutagenic with 4AB, BAP,
CSC, or WPW in the spiral assay based on the observed
subadditive and additive effects.  The additive result
observed by Donnelly et al. (1990) when PCP and nontoxic
doses of BAP were combined in the plate assay was observed
here in the spiral assay.  However, the combination of PE
with PCP elicited a statistically significant positive
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nonadditive response, indicating that PCP may be slightly
comutagenic with PE.
5.6 Spiral and Plate Assays
Interaction studies in the plate-incorporation assay
are more time-consuming and require significantly more
material than the spiral assay.  A range of eleven doses can
be generated on one spiral plate, whereas eleven plates
would be required to generate the same dose response in the
plate assay.  The spiral assay appears to be a simple, time-
saving alternative to the plate-incorporation assay for
testing combinations of two or more direct-acting compounds.
However, both assays have demonstrated the difficulty
in determining the response of bacteria to promutagens
metabolized with exogenous mammalian activation, although
the plate-incorporation assay seems to be more suited to
interaction studies with promutagens than the spiral assay.
Clearly, there are concerns about the result of combining a
compound that requires a low concentration of S9 for
activation, such as BAP, with a compound that requires a
relatively higher concentration of S9, such as 4AB.  Is the
effect of one compound being expressed at the higher levels
of S9 required for the other compound?  In the cases where
two compounds require similar concentrations of activating
enzymes, additivity may be more likely to be observed—
assuming a sufficient concentration of enzymes are present.
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5.7 Implications for Exposures of Humans to Multiple
Agents
As discussed in the Introduction, most human exposure
to potentially harmful compounds occurs in the form of
complex mixtures.  The additivity assumption has been used
to simplify risk assessments for exposure to complex
mixtures.  Although the present results with Salmonella
cannot be extrapolated directly to humans, the results do
suggest that the additivity assumption may have limited
validity and applicability to such risk assessments.
Considering the results in this report for direct-
acting mutagens along with those reported previously in the
literature (see Introduction), the additivity assumption may
be reasonable for such compounds.  However, few
environmental mutagens are direct-acting.  Most direct-
acting mutagens are alkylating agents that are used in
medicine, but these are not generally present in the
environment.  Consequently, the assumption of additivity,
although reasonable for these types of mutagens, may have
little general applicability or validity for most types of
potentially harmful environmental mutagens to which humans
are exposed.
With regard to indirect-acting mutagens, the present
study and previous studies in the literature provide little
justification for the additivity assumption.
Epidemiological studies of cigarette smokers that drank
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alcohol (Tuyns et al., 1977) found a multiplicative
(superadditive) effect of oesophageal cancer.  A cohort
study (Selikoff et al., 1973) of smoking and nonsmoking
insulation workers exposed to chrysotile and amosite found a
greater than additive relative risk for laryngeal cancer in
the workers that smoked. Whittemore and McMillan (1983)
found that lung cancer death in tobacco-smoking uranium
miners exposed to radioactive alpha emissions was more than
expected than for lung cancer deaths due to radiation
exposure alone and smoking alone.  Therefore, we see that
there is evidence in humans of superadditive effects
involving one of the complex mixtures (CSC) used in the
present study.
The present study has found that nearly all
combinations of indirect-acting agents resulted in
subadditivity; whereas, studies of other classes of
compounds in the literature have found superadditivity.
Compounds requiring metabolic activity are the most
prevalent type of environmental mutagens to which humans are
exposed.  Thus, the limited evidence for additivity for this
type of mutagen casts doubt on the continued use of the
additivity assumption for many complex mixtures.
Admittedly, data from a bacterial system may have
limited validity for animal systems.  However, rodent
studies of binary combinations of mutagens have not been
reported widely in the literature and are unlikely to be
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performed due to the complexity and cost of such studies.
Thus, for the near future, data from short-term tests, such
as the Salmonella assay, will remain the primary source of
information on the mutagenic acitivity of binary mixtures of
mutagens.
Considering the fact that most organic compounds that
have been declared to be human carcinogens by the
International Agency for Research on Cancer (lARC) are also
mutagenic in Salmonella (Shelby and Zeiger, 1990), the
present study should be viewed as having some validity for
human exposures.  The present study suggests that regulatory
agencies might reconsider the use of the additivity
assumption for risk assessements of certain types of complex
mixtures.
5.8 Future Work and Reconunendations
The current methods for the spiral assay should be
modified in order to perform interaction studies better with
binary combinations of mutagens.  The delivery of a greater
concentration of S9 to the plate is required in order to
assure that there are enough isozymes to metabolize both
compounds.  This could be acheived in several ways.  The
concentration of 39 in the S9 mix could be increased.
Alternatively, the S9 mix could be applied several times to
the plate to deliver a greater total concentration to the
plate.  Exploring the idea of using twice as much S9 mix for
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the binary combination than for the single compounds is also
worthwhile.
It would be very useful to have the spiral assay be
analogous directly with the plate assay.  This could be
accomplished with a constant deposition of S9 mix.  The
uniform cam currently expells a prohibitively small volume
of liquid to deposit the S9 mix in this manner.  A solution
would be to install a cam with an increased slope so that
more liquid would be expelled per spiral.
A standard analysis and criteria for determining
additivity would also be useful in interaction studies.
Questions such as whether a 95% confidence limit is too
restrictive should be considered.  If no statistical
analysis is attempted, there should be an absolute MIR value
above which nonadditivity is established.  Also, it appears
that several doses of the compound tested under varying
metabolic activation conditions, if required, is desirable.
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